1,4‐Dihydro‐3,6‐dipyrazin‐2‐yl‐1,2,4,5‐tetra­zine–benzene‐1,3‐dicarboxylic acid (1/1). Retraction

Publisher: Lyceum Books

ISSN: 1553-555x

Source: Best Practices in Mental Health, Vol.63, Iss.4, 2007-04, pp. : e21-e21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract